HomeTORNTPHARM • NSE
add
Torrent Pharmaceuticals Ltd
Previous close
₹2,953.70
Day range
₹2,945.65 - ₹3,005.00
Year range
₹1,772.05 - ₹3,005.00
Market cap
1.00T INR
Avg Volume
231.56K
P/E ratio
60.57
Dividend yield
0.94%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 27.45B | 10.18% |
Operating expense | 13.73B | 9.78% |
Net income | 4.49B | 51.70% |
Net profit margin | 16.37 | 37.68% |
Earnings per share | 13.27 | 56.49% |
EBITDA | 8.80B | 25.48% |
Effective tax rate | 28.80% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.04B | 38.91% |
Total assets | 150.61B | 0.32% |
Total liabilities | 82.04B | -6.91% |
Total equity | 68.56B | — |
Shares outstanding | 338.45M | — |
Price to book | 14.58 | — |
Return on assets | — | — |
Return on capital | 15.67% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 4.49B | 51.70% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology and pediatrics. Wikipedia
Founded
1959
Headquarters
Website
Employees
15,718
